6 X Valupak Vitamin D 1000Iu

Product Information

No new patients to receive prescriptions in primary care. Patients already receiving Red Medicines in primary care should be handled on a case by case basis with the support of the Medicines Optimisation team. Tablets may be crushed and dispersed in water if needed. Liquid can be made specially if required. See here for general advice on dispersing tablets. actinomycin (a medicine used to treat some forms of cancer) as it may interfere with the metabolism of vitamin D

Intramuscular (IM) Injection = as per Notts APC Alcohol Dependence Guidelines. May be administered in primary care by appropriately trained professionals using the correct administration technique.Colecalciferol is metabolised by microsomal hydroxylase to form 25-hydroxycolecalciferol (25(OH)D 3, calcidiol), the primary storage form of vitamin D 3. 25(OH)D 3 undergoes a secondary hydroxylation within the kidney to form the predominant active metabolite 1,25-hydroxycolecalciferol (1,25(OH) 2D 3, calcitriol). The metabolites circulate in the blood bound to a specific α-globin. If Colecalciferol is combined with metabolites or analogues of vitamin D careful monitoring of serum calcium levels is recommended.

Liquid : Fultium-D3 ® Drops 2740 units/ml. 25ml bottle. 12 drops contain 800 units. Pro D3 ® 2000 units/ ml drops may be supplied as an alternative to Fultium D3 ® drops during supply problems Use of certain concomitant medications (e.g. anticonvulsant medications glucocorticoids, anti-retrovirals) Colecalciferol 1 000 IU is the equivalent of 25 micrograms vitamin D 3, which is involved in bone formation.While Valupak Vitamin D 3 is unlikely to cause side effects, some people may experience side effects. The active ingredient colecalciferol is identical to the Colecalciferol that is found in the human body. It is found in the diet and is also produced in the skin after exposure to the sun.